SCHEMBL9000174

SCHEMBL9000174

Clc1cc2nc(-c3ccccc3)[nH]c2cc1Cl

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 3/20 0.73
KDM4E B2RXH2 4/20 0.68
ALDH1A1 P00352 4/20 0.68
HPGD P15428 4/20 0.68
MAPT P10636 4/20 0.68
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
TP53 P04637 2/20 0.68
HSD17B10 Q99714 2/20 0.68
CYP3A4 P08684 1/20 0.68
MAPK1 P28482 1/20 0.68
FTO Q9C0B1 1/20 0.68
NPC1 O15118 6/20 0.59
RAB9A P51151 6/20 0.59
GAA P10253 2/20 0.59
SMN1; SMN2 Q16637 4/20 0.58
GLA P06280 1/20 0.58
HTT P42858 1/20 0.58
GFER P55789 1/20 0.58
RCE1 Q9Y256 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30615082 1.00 RHEB (0.73) RHEBKDM4EALDH1A1HPGDMAPT
SCHEMBL30615124 0.87 KDM4E (0.60) RHEBKDM4EALDH1A1HPGDMAPT
SCHEMBL29091545 0.87 KDM4E (0.60) RHEBKDM4EALDH1A1HPGDMAPT
SCHEMBL19175922 0.87 KDM4E (0.60) RHEBKDM4EALDH1A1HPGDMAPT
SCHEMBL3132123 0.85 NPC1 (0.68) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL11225571 0.84 RHEB (1.00) RHEBKDM4EALDH1A1HPGDMEN1
SCHEMBL23709742 0.84 RHEB (0.61) RHEBKDM4EALDH1A1HPGDMAPT
SCHEMBL21011385 0.83 NPC1 (0.70) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL903717 0.83 NPC1 (0.66) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL10736415 0.83 RHEB (0.69) RHEBKDM4EALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210371992-A1 ELECTROCHEMICAL ORGANIC REACTION SETUP AND METHODS PIRAMAL PHARMA LIMITED (IN) 2021-12-02 US disclosed
US-20170210741-A1 Benzimidazole Compounds, Use As Inhibitors of WNT Signaling Pathway in Cancers, and Methods for Preparation Thereof SOUTHERN RESEARCH INSTITUTE 2017-07-27 US disclosed
EP-0445627-B1 Silver halide photographic light-sensitive materials FUJI PHOTO FILM CO LTD (JP) 1996-09-11 EP disclosed
EP-0097720-A1 PROCESS FOR PREPARING SILVER HALIDE EMULSION KONICA CORPORATION (JP) 1984-01-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170210741-A1 Benzimidazole Compounds, Use As Inhibitors of WNT Signaling Pathway in Cancers, and Methods for Preparation Thereof WNT1, WNT3, CTNNB1 RHEB 1379/4885KDM4E 1363/4885ALDH1A1 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.